News
September 20, 2023
OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs
May 23, 2023
OnKure Therapeutics Announces $54 Million Series C Financing
December 6, 2022
OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations
- View All News